Bendamustine 100 mg Injection — Chemotherapy for Leukemia and Lymphoma Bendamustine 100 mg Injection contains bendamustine hydrochloride, a potent chemotherapy agent from the alkylating class used in the treatment of chronic lymphocytic leukemia (CLL) and various forms of non-Hodgkin’s lymphoma, including mantle cell lymphoma. The medicine works by damaging cancer cell DNA, preventing cell division and leading to cancer cell death. Bendamustine is administered via intravenous infusion under strict medical supervision in oncology centers. Due to its effects on the immune system and blood counts, patients require regular laboratory monitoring throughout treatment. Available in Pakistan through licensed oncology pharmacies and hospital suppliers, Bendamustine 100 mg Injection is a prescription-only medicine used as part of specialized cancer care.